Profil
Nobuhito Yanai currently works at EVERLTH Co., Ltd., as Director & General Manager-Administration from 2022 and Medipal Holdings Corp., as Executive Officer & Deputy GM-Administration.
Postes actifs de Nobuhito Yanai
| Sociétés | Poste | Début |
|---|---|---|
| MEDIPAL HOLDINGS CORPORATION | Corporate Officer/Principal | - |
EVERLTH Co., Ltd.
 EVERLTH Co., Ltd. Medical DistributorsDistribution Services Part of Medipal Holdings Corp., EVERLTH Co., Ltd. is a healthcare supplier that supports community medicine in five prefectures in the Chugoku region. The company is based in Hiroshima, Japan. The Japanese company provides services that support pharmaceutical companies and medical institutions with high-performance logistics of pharmaceuticals. EVERLTH Co. uses logistics and information networks that cover the whole country to quickly and stably supply excellent drugs. The company contributes to the community and society as a specialist with a wide range of knowledge based on the stable supply of pharmaceuticals. The company also provides new value from collaboration with ICT companies. EVERLTH Co. was acquired by Kuraya Sanseido Co. Ltd. on October 01, 2004 for $169.99 million. | Directeur Administratif | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MEDIPAL HOLDINGS CORPORATION | Distribution Services |
| Entreprise privées | 1 |
|---|---|
EVERLTH Co., Ltd.
EVERLTH Co., Ltd. Medical DistributorsDistribution Services Part of Medipal Holdings Corp., EVERLTH Co., Ltd. is a healthcare supplier that supports community medicine in five prefectures in the Chugoku region. The company is based in Hiroshima, Japan. The Japanese company provides services that support pharmaceutical companies and medical institutions with high-performance logistics of pharmaceuticals. EVERLTH Co. uses logistics and information networks that cover the whole country to quickly and stably supply excellent drugs. The company contributes to the community and society as a specialist with a wide range of knowledge based on the stable supply of pharmaceuticals. The company also provides new value from collaboration with ICT companies. EVERLTH Co. was acquired by Kuraya Sanseido Co. Ltd. on October 01, 2004 for $169.99 million. | Distribution Services |